GeoVax Labs Inc. (GOVX)
GeoVax Labs Statistics
Share Statistics
GeoVax Labs has 13.84M shares outstanding. The number of shares has increased by 447.38% in one year.
| Shares Outstanding | 13.84M |
| Shares Change (YoY) | 447.38% |
| Shares Change (QoQ) | 46.67% |
| Owned by Institutions (%) | 11.81% |
| Shares Floating | 13.73M |
| Failed to Deliver (FTD) Shares | 222 |
| FTD / Avg. Volume | 0.04% |
Short Selling Information
The latest short interest is 815.23K, so 8.64% of the outstanding shares have been sold short.
| Short Interest | 815.23K |
| Short % of Shares Out | 8.64% |
| Short % of Float | 8.67% |
| Short Ratio (days to cover) | 1.79 |
Valuation Ratios
The PE ratio is -0.51 and the forward PE ratio is -0.84. GeoVax Labs's PEG ratio is 0.01.
| PE Ratio | -0.51 |
| Forward PE | -0.84 |
| PS Ratio | 3.24 |
| Forward PS | 0 |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0.01 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for GeoVax Labs.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.55, with a Debt / Equity ratio of 0.
| Current Ratio | 2.55 |
| Quick Ratio | 2.55 |
| Debt / Equity | 0 |
| Debt / EBITDA | 0 |
| Debt / FCF | 0 |
| Interest Coverage | -1176.34 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $232.62K |
| Profits Per Employee | $-1.47M |
| Employee Count | 17 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -31.97% in the last 52 weeks. The beta is 3.71, so GeoVax Labs's price volatility has been higher than the market average.
| Beta | 3.71 |
| 52-Week Price Change | -31.97% |
| 50-Day Moving Average | 1.34 |
| 200-Day Moving Average | 2.35 |
| Relative Strength Index (RSI) | 45.47 |
| Average Volume (20 Days) | 596.43K |
Income Statement
In the last 12 months, GeoVax Labs had revenue of 3.95M and earned -24.99M in profits. Earnings per share was -4.82.
| Revenue | 3.95M |
| Gross Profit | 3.95M |
| Operating Income | -25.14M |
| Net Income | -24.99M |
| EBITDA | -24.88M |
| EBIT | -24.97M |
| Earnings Per Share (EPS) | -4.82 |
Balance Sheet
The company has 5.51M in cash and 0 in debt, giving a net cash position of 5.51M.
| Cash & Cash Equivalents | 5.51M |
| Total Debt | 0 |
| Net Cash | 5.51M |
| Retained Earnings | -129,356.1B |
| Total Assets | 8.16M |
| Working Capital | 4.83M |
Cash Flow
In the last 12 months, operating cash flow was -24,675.5B and capital expenditures 0, giving a free cash flow of -24,675.5B.
| Operating Cash Flow | -24,675.5B |
| Capital Expenditures | 0 |
| Free Cash Flow | -24,675.5B |
| FCF Per Share | -4757148.68 |
Margins
Gross margin is 100%, with operating and profit margins of -635.83% and -631.98%.
| Gross Margin | 100% |
| Operating Margin | -635.83% |
| Pretax Margin | -631984212.72% |
| Profit Margin | -631.98% |
| EBITDA Margin | -629.03% |
| EBIT Margin | -635.83% |
| FCF Margin | -623973619.42% |
Dividends & Yields
GOVX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for GOVX is $14.5, which is 1350% higher than the current price. The consensus rating is "Buy".
| Price Target | $14.5 |
| Price Target Difference | 1350% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
Stock Splits
The last stock split was on Jan 31, 2024. It was a backward split with a ratio of 1:15.
| Last Split Date | Jan 31, 2024 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | -28.94 |
| Piotroski F-Score | 4 |